Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000575417 | SCV000662347 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575417 | SCV000689946 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000979908 | SCV001127856 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575417 | SCV002528802 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-22 | criteria provided, single submitter | curation | |
Ce |
RCV002510922 | SCV002822641 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | MSH2: BP4 |
Gene |
RCV002510922 | SCV004169115 | uncertain significance | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing |
All of Us Research Program, |
RCV004000864 | SCV004828870 | likely benign | Lynch syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |